[1] [4] This indication extends to adolescents aged 12 years and older with BMI 95th percentile for age and sex
A 2022 randomized trial of exenatide did not meet its primary endpoint for reducing heavy drinking days in the overall population, though exploratory analyses suggested potential benefits in participants with obesity
CrossRef Synergistic Impact of Sarcopenia and T2DM on Mortality in Metabolic DysfunctionAssociated Steatotic Liver Disease (MASLD) Qi Zhou, Peiyan Liu, Lixiang Li, Tengfei Yin, Hao Bai, Yanqing Li The FASEB Journal .2025;[Epub] CrossRef Early-Life Nutritional Determinants of Pediatric MASLD Johanna K
Benefits Of Microdosing Tirzepatide Fewer Side Effects During Dose Escalation Slower titration reduces the intensity of gastrointestinal effects for many patients, which explains why clinicians experiment with smaller steps when early nausea threatens continuation
Also Read: Indias GLP1 moment is herethe weightloss drug wars begin Anshul Gupta of Avendus Capital frames the opportunity plainly